4/A
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000905718-19-000065
Director sold 62,925 shares at $29.70 ($1,869,168)
From the SEC's structured data for this filing
Trades in this filing
EMSTER KURT VON · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-12-18 | Sale : show line 1 in the form | −62,925 | $29.70 | $1,869,168 | 1,171,268 | I |
| Open-market sales · 62,925 sh · avg $29.70 · $1,869,168 | ||||||
Loading xslF345X03/crisprfm4a_dec192018.xml…